Aim of the meeting: The main objective of the conference will be to provide a complete summary of the state-of-art of the pharmacology and therapeutic exploitation of the endocannabinoid system, focusing on the current and future directions undertake

When? 17th October 2014
Where? University of Bern (Bern, Switzerland)

Duration: 1-day (coffee break and lunch break included)
Free attendance
Organization: Lectures, oral presentations and poster session

Fields of interest: Life and Medical Sciences with a special focus on the biology, biochemistry and pharmacology of the endocannabinoid system

Confirmed international speakers:

Prof. Steve Alexander - University of Nottingham (United Kingdom)

Prof. Vincenzo Di Marzo - National Research Council (Italy)

Prof. Raphael Mechoulam - Hebrew University (Israel)

Prof. Daniele Piomelli - University of Irvine (USA)/Italian Institute of Technology (Italy)

Prof. Christoph Abels - Dr. August Wolff GmbH & Co. KG Arzneimittel (Germany)

Dr. Jürgen Fingerle - Hoffman La Roche (Switzerland)

We strongly encourage students (MSc and PhD) and scientists to attend the meeting and actively participate by presenting their research activity in the poster session (some contributions might be chosen for oral presentation). The best poster will be awarded. Deadline for abstract submission: 26th of September 2014.
Please register as soon as possible by contacting Dr. Andrea Chicca (chicca@ibmm.unibe.ch) or Prof. Jürg Gertsch (gertsch@ibmm.unibe.ch), Institute of Biochemistry and Molecular Medicine, University of Bern, Switzerland.

View PDF

More details

Find an actor

BioTaiwan 201819.07.2018

BioTaiwan Exhibition 2018 will be held from 19 to 22 July at the TWTC Nangang Exhibition Hall in Taipei, Taiwan.

GENOME JUMPER

Un jeu mobile pour explorer la diversité humaine.
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn